Fig. 1From: No clinically significant pharmacokinetic interactions between dolutegravir and daclatasvir in healthy adult subjectsMean plasma concentration-time profiles of dolutegravir (DTG) administered with and without daclatasvir (DCV). Abbreviations: q24h, every 24 h; SD, standard deviationBack to article page